Abstract
Toxoplasma gondiiis an opportunistic parasite that infects at least one-third of the world population. New treatments for the disease (toxoplasmosis) are needed since current drugs are toxic to patients. Microtubules are essential cellular structures built from tubulin that show promise as antimicrobial drug targets. Microtubules can be regulated by chemical modification, such as acetylation on lysine 40 (K40). To determine the role of K40 acetylation inToxoplasmaand whether it is a liability to the parasite, we performed mutational analyses of the α-tubulin gene. Our results indicate that parasites cannot survive without K40 acetylation unless microtubules are stabilized with a secondary mutation. Additionally, we identified the parasite enzyme that acetylates α-tubulin (TgATAT). Genetic disruption ofTgATATcaused severe defects in parasite replication, further highlighting the importance of α-tubulin K40 acetylation inToxoplasmaand its promise as a potential new drug target.
Funding Information
  • HHS | National Institutes of Health (AI116496)
  • HHS | National Institutes of Health (AI108393, AI089808)
  • American Heart Association (15PRE25550023)
  • Pharmaceutical Research and Manufacturers of America Foundation

This publication has 69 references indexed in Scilit: